Sign In
Buy LLY
$1,125.38
+42.15 (+3.89%)
At Close: Jun 04, 2026
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:01am, Tuesday, 07'th Oct 2025
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:51am, Tuesday, 07'th Oct 2025
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Approximately 80% of Omvoh-treated patients in the LUCENT-3 study who achieved clinical remission at one year maintained long-term, corticosteroid-free clinical and endoscopic remission At four years,
Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal
07:35pm, Monday, 06'th Oct 2025
After tanking in early August, the world's most valuable pharmaceutical stock has roared back with a vengeance. That firm is Eli Lilly and Company NYSE: LLY, the maker of the wildly popular weight los
Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know
03:01pm, Monday, 06'th Oct 2025
LLY shares have jumped 16% last week as Pfizer's landmark government deal boosted investor confidence across the pharma sector.
Trump's Drug Price Cuts: Boom or Bust for These 3 Pharma Giants
02:21pm, Monday, 06'th Oct 2025
When investors hear that a company will lower prices on its products, their instinctive reaction is to expect a sequential decline in margins and profits, which is not entirely incorrect. However, som
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
Eli Lilly: Beyond Weight Loss
09:56am, Monday, 06'th Oct 2025
Eli Lilly (LLY 1.15%) is now known for its weight loss drugs. Its stock has risen 150% since mid-2022 because of high demand for Mounjaro (tirzepatide approved to treat type 2 diabetes) and Zepbound (
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
03:12am, Monday, 06'th Oct 2025
Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforc
Eli Lilly (LLY) Laps the Stock Market: Here's Why
06:46pm, Friday, 03'rd Oct 2025
Eli Lilly (LLY) closed the most recent trading day at $839.87, moving +2.44% from the previous trading session.
Why Shares of Eli Lilly Soared This Week
10:47am, Friday, 03'rd Oct 2025
Shares in Eli Lilly (LLY 2.73%) had risen 13.2% in the week to Friday morning. The move comes at a time when peer Pfizer announced a deal with the Trump administration that gave that pharmaceutical co
Top 50 High-Quality Dividend Growth Stocks For October 2025
10:46am, Friday, 03'rd Oct 2025
I track a universe of 50 high-quality dividend growth stocks to identify opportune investments based on valuation and future return potential. As of October 2, 2025, 22 stocks offer attractive future
Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies
09:00am, Friday, 03'rd Oct 2025
BOSTON--(BUSINESS WIRE)-- #AI--Kernal Bio retains strategic independence, while gaining access to shared resources, operational support and Lilly's global network of experts.
Buy LLY Stock At $820?
08:35am, Friday, 03'rd Oct 2025
The entire pharmaceutical sector is experiencing a rerating this week, as investors realize the adverse impact of tariffs and drug price cuts won't be as severe as previously anticipated. While most m
How I Would Build An Ultra-High-Conviction Retirement Portfolio Right Now
07:30am, Friday, 03'rd Oct 2025
Building a resilient retirement portfolio requires a mix of disruption-proof income from REITs, midstream energy, and high-yielding assets, plus growth stocks and ETFs. Current market challenges—AI
